Related Experiment Video

Updated: May 15, 2026

Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion
03:22

Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion

Published on: November 10, 2023

TLR2 in pleural fluid is modulated by talc particles during pleurodesis

Karolina Jankovicova1, Katerina Kondelkova, Petr Habal

  • 1Department of Clinical Immunology and Allergy, Faculty of Medicine and University Hospital in Hradec Kralove, Charles University in Prague, Sokolska Street 581, 500 05 Hradec Kralove, Czech Republic. karolina.jankovicova@fnhk.cz

Clinical & Developmental Immunology
|January 11, 2013
PubMed

Insights

Toll-like receptor 2 (TLR2) levels in pleural fluid increase significantly after talc pleurodesis for malignant pleural effusion. Higher early soluble TLR2 levels indicate a favorable prognosis in these patients.

Area of Science:

  • Immunology
  • Pulmonology
  • Oncology

Background:

  • Malignant pleural effusion is a common complication of cancer.
  • Talc pleurodesis is a standard procedure to manage malignant pleural effusion.
  • The role of immune molecules like Toll-like receptor 2 (TLR2) in talc pleurodesis is not fully understood.

Purpose of the Study:

  • To investigate the role of TLR2 in the pleural space during thoracoscopic talc pleurodesis.
  • To analyze soluble and membrane-bound TLR2 in pleural fluid.
  • To determine the prognostic value of TLR2 expression in patients with malignant pleural effusion undergoing talc pleurodesis.

Main Methods:

  • Analysis of pleural fluid collected at three time points: pre-procedure, 2 hours post-procedure, and 24 hours post-procedure.
  • Quantification of soluble TLR2 and membrane-bound TLR2 on granulocytes using flow cytometry.
  • Retrospective classification of patients into prognostically favorable and unfavorable groups.

Main Results:

  • Soluble TLR2 levels in pleural fluid significantly increased approximately 8-fold by 24 hours after talc pleurodesis.
  • Membrane-bound TLR2 expression on granulocytes significantly decreased after talc exposure.
  • Patients with a favorable prognosis exhibited over 3-fold higher soluble TLR2 levels in pleural fluid at 2 hours post-procedure.

Conclusions:

  • Talc pleurodesis induces a significant increase in soluble TLR2 in the pleural space.
  • Decreased membrane TLR2 on granulocytes suggests a modulation of immune cell response.
  • Early elevation of soluble TLR2 in pleural fluid is a potential biomarker for favorable prognosis in malignant pleural effusion treated with talc pleurodesis.

More Related Videos

A Pleural Effusion Model in Rats by Intratracheal Instillation of Polyacrylate/Nanosilica03:32

A Pleural Effusion Model in Rats by Intratracheal Instillation of Polyacrylate/Nanosilica

Published on: April 12, 2019

Related Concept Videos

Pleura of the Lungs01:13

Pleura of the Lungs

The lungs are nestled in a cavity, shielded by the pleura. The pleura, a form of serous membrane, wraps around each lung. This membrane arrangement consists of two layers: the visceral and parietal pleurae. The visceral pleura lines the surface of the lungIn contrast, the parietal pleura is the outer layer and contacts to the thoracic wall, the mediastinum, and the diaphragm. The hilum is the point of connection between the visceral and parietal layers. The space between the parietal and...
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pneumothorax II: Pathophysiology01:08

Pneumothorax II: Pathophysiology

Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance between...
Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
Endoscopic Studies II: Thoracocentesis01:26

Endoscopic Studies II: Thoracocentesis

Thoracentesis(Thoracocentesis), commonly known as pleural tap, is a medical procedure where a 22 gauge needle is inserted into the pleural space, the area between the lung and chest wall. This procedure is commonly performed to diagnose or treat various respiratory disorders.
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...